Anna-Polina S Shurygina (Anna-Polina Shurygina, Anna Polina Shurigina)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Particulate Matter

Respiratory Syncytial Virus

Immune Response

Dendritic Cells

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Anna-Polina S Shurygina, Natalia V Zabolotnykh, Tatiana I Vinogradova, Maria L Vitovskaya, Marine Z Dogonadze, Kirill A Vasilyev, Zhanna V Buzitskaya, Petr K Yablonskiy, Dmitriy A Lioznov, Marina A Stukova
TB/FLU-06E Influenza Vector-Based Vaccine in the Complex Therapy of Drug-Susceptible and Drug-Resistant Experimental Tuberculosis. Pharmaceutics 16 (7) (2024)
Anna-Polina S Shurygina, Natalia V Zabolotnykh, Tatiana I Vinogradova, Maria L Vitovskaya, Marine Z Dogonadze, Kirill A Vasilyev, Zhanna V Buzitskaya, Petr K Yablonskiy, Dmitriy A Lioznov, Marina A Stukova
TB/FLU-06E Influenza Vector-Based Vaccine in the Complex Therapy of Drug-Susceptible and Drug-Resistant Experimental Tuberculosis. Pharmaceutics 16 (7) (2024)
Anna-Polina S Shurygina, Natalia V Zabolotnykh, Tatiana I Vinogradova, Maria L Vitovskaya, Marine Z Dogonadze, Kirill A Vasilyev, Zhanna V Buzitskaya, Petr K Yablonskiy, Dmitriy A Lioznov, Marina A Stukova
TB/FLU-06E Influenza Vector-Based Vaccine in the Complex Therapy of Drug-Susceptible and Drug-Resistant Experimental Tuberculosis. Pharmaceutics 16 (7) (2024)
Anna-Polina S Shurygina, Natalia Zabolotnykh, Tatiana Vinogradova, Berik Khairullin, Markhabat Kassenov, Ainur Nurpeisova, Gulbanu Sarsenbayeva, Abylai Sansyzbay, Kirill Vasilyev, Janna Buzitskaya, Andrey Egorov, Marina Stukova
Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis. International journal of molecular sciences 24 (8) (2023)
Anna-Polina S Shurygina, Natalia Zabolotnykh, Tatiana Vinogradova, Berik Khairullin, Markhabat Kassenov, Ainur Nurpeisova, Gulbanu Sarsenbayeva, Abylai Sansyzbay, Kirill Vasilyev, Janna Buzitskaya, Andrey Egorov, Marina Stukova
Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis. International journal of molecular sciences 24 (8) (2023)
Anastasia Pulkina, Kirill A Vasilyev, Arman Muzhikyan, Mariia V Sergeeva, Ekaterina Romanovskaya-Romanko, Anna-Polina S Shurygina, Marina A Shuklina, Andrey Vasin, Marina Stukova, Andrej Egorov
IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice. International journal of molecular sciences 24 (14) (2023)
Anna-Polina S Shurygina, Natalia Zabolotnykh, Tatiana Vinogradova, Berik Khairullin, Markhabat Kassenov, Ainur Nurpeisova, Gulbanu Sarsenbayeva, Abylai Sansyzbay, Kirill Vasilyev, Janna Buzitskaya, Andrey Egorov, Marina Stukova
Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis. International journal of molecular sciences 24 (8) (2023)
Kirill A Vasilyev, Anna-Polina S Shurygina, Natalia Zabolotnykh, Mariia V Sergeeva, Ekaterina A Romanovskaya-Romanko, Anastasia Pulkina, Janna Buzitskaya, Marine Z Dogonadze, Tatiana I Vinogradova, Marina A Stukova
Enhancement of the Local CD8+ T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens. Vaccines 9 (11) (2021)
Kirill A Vasilyev, Anna-Polina S Shurygina, Mariia V Sergeeva, Marina Stukova, Andrej Egorov
Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs. Microorganisms 9 (4) (2021)
Mariia V Sergeeva, Ekaterina Romanovskaya-Romanko, Natalia Zabolotnyh, Anastasia Pulkina, Kirill A Vasilyev, Anna-Polina S Shurygina, Janna Buzitskaya, Yana A Zabrodskaya, Artem Fadeev, Andrey V Vasin, Tatiana I Vinogradova, Marina A Stukova
Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs. Vaccines 9 (4) (2021)